MeMed Raises $93M To Decode Body’s Immune Response
MeMed has developed an immune-based protein signature, which distinguishes between bacterial and viral infections.
January 11, 2022
Medical Diagnostics Tech Firm MeMed Raises $70M
Founded in 2009, MeMed has developed a number of tools for innovative diagnostic testing and platforms.
September 20, 2018
MeMed Gets $9.2M US Defense Contract
April 20, 2017 | MeMed, an Israeli start-up developing a reliable test to distinguish bacterial from viral infections, has secured a $9.2 million contract by the Defense Threat Reduction Agency (DTRA), a branch of the US Department of Defense (DoD) to improve clinical applications of its technology. The contract will fund the completion of MeMed’s pioneering point of […]
April 20, 2017
Meet The Top Israeli Startups Revolutionizing Everyday Healthcare
Israeli startups are changing healthcare as we know it, with a host of innovative solutions.
December 23, 2015